MedTrace Logo

Step up to Health, Nigeria! Impact of 2022 World Cancer Day Walk on Health Behaviors Among Nigerians

NCT05239325 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 527

Last updated 2022-02-14

No results posted yet for this study

Summary

Cancer awareness is a critical element of cancer prevention and control. Creating public awareness on risk factors, preventative strategies, and the importance of early screening is the foundation upon which a cancer control program must be constructed. The purpose of this study is to describe the sociodemographic and risk factor distribution of the Abuja, Nigeria "World Cancer Day Walk" participants according to their motive for participating in the event (free cancer screening versus fun/activities), and secondarily, to investigate the impact of the event on educating attendees from the general population about cancer prevention and screening, in particular the importance of being physically active and maintaining a healthy body weight. Obesity is a known risk factor contributing to the development of cancer and NCD's.

Conditions

  • Cancer Prevention

Interventions

BEHAVIORAL

World Cancer Day Walk

Health literacy education (cancer prevention and healthy lifestyle) and free breast, prostate, cervical cancer screening

Sponsors & Collaborators

  • Project PINKBLUE, Health and Psychological Trust Centre

    collaborator UNKNOWN

  • University Of Nigeria Teaching Hospital

    collaborator NETWORK

  • Vaughan A. Lewis Institute for Research and Innovation

    collaborator OTHER

  • Columbia University

    collaborator OTHER

  • AshtaYoga, LLC

    lead INDUSTRY

Principal Investigators

  • Leigh Leibel, MSc · Columbia University

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-05
Primary Completion
2022-02-05
Completion
2022-02-05

Countries

  • Nigeria

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05239325 on ClinicalTrials.gov